Hikari Power’s Novartis NVS Stock Holding History

Hikari Power’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-5,301	Closed	-$344K	–	90
2016 Q1	$344K	Hold	5,301	–	–	0.04%	79
2015 Q4	$409K	Hold	5,301	–	–	0.06%	77
2015 Q3	$437K	Sell	5,301 -279	-5%	-$24.8K	0.07%	58
2015 Q2	$492K	Hold	5,580	–	–	0.07%	58
2015 Q1	$493K	Hold	5,580	–	–	0.07%	56
2014 Q4	$461K	Hold	5,580	–	–	0.06%	53
2014 Q3	$471K	Hold	5,580	–	–	0.07%	46
2014 Q2	$453K	Hold	5,580	–	–	0.07%	46
2014 Q1	$425	Buy	+5,580	New	+$407K	0.05%	45

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Hikari Power's NVS Position: Q2 2016 in Review

Hikari Power sold out of Novartis (NVS) in Q2 2016, closing a stake of 5,301 shares — an estimated $344K sold.

Hikari Power first reported a position in NVS in Q1 2014 and held it in 9 quarters. The position peaked at $493K in Q1 2015. 878 funds tracked by Wall St. Rank hold NVS as of Q2 2016.

Hikari Power reported no remaining Novartis position as of Q2 2016 after selling out during the quarter.
Hikari Power sold 5,301 Novartis shares in Q2 2016, an estimated $344K.
Hikari Power first reported a position in Novartis in Q1 2014 and held it in 9 quarters.
Hikari Power's Novartis position peaked at $493K in Q1 2015.
878 funds tracked by Wall St. Rank held Novartis as of Q2 2016.

Based on Hikari Power's 13F filing for Q2 2016, filed 3 Aug 2016.